Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/09 → 11/25/10 |
Funding
- Pfizer Inc.: $10,318.00
Phase 3 Randomized, Double-blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of CP-690,550 in Patients with Active Rheumatoid Arthritis on Background Methotrexate
- Lohr, Kristine (PI)
- Crofford, Leslie (CoI)